STOCK TITAN

Endexx Corporation Announces Participation in the Benzinga Virtual Cannabis Capital Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Endexx Corporation (OTC PINK:EDXC) will present at the Benzinga Cannabis Capital Conference on February 25-26, 2021, at 1:50 pm EST. Shareholders can register for a free spectator pass. The event promises an interactive forum featuring presentations from leading figures in the cannabis industry, allowing participants to connect with top executives and investors globally. Endexx, through its division CBD Unlimited, focuses on all-natural CBD products aimed at therapeutic relief, with a range of offerings for both humans and pets based on clinical research.

Positive
  • Participation in the Benzinga Cannabis Capital Conference provides visibility and engagement opportunities with investors.
  • Focus on all-natural CBD products positions the company in a growing market with diverse product offerings.
Negative
  • None.

Cave Creek, AZ, Feb. 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Endexx Corporation (OTC PINK:EDXC) will be presenting at the Benzinga Cannabis Capital Conference taking place on February 25-26, 2021 at 1:50 pm EST/11:50 am MST. We invite our shareholders to sign up to get a free spectator pass for the event: https://events.benzinga.com/ccc-free-registration

About Benzinga Cannabis Capital Conference

Benzinga's virtual Cannabis Capital Conference is guaranteed to offer participants all the benefits of an immersive and robust in-person conference from any remote location. The conference will feature an interactive forum of live presentations from top CEOs, investors, and leaders in the cannabis space. Don't miss this opportunity to connect with THE cannabis movers and shakers from across the globe.

For more information and/or to register for the conference please visit: https://events.benzinga.com/ccc-free-registration

We look forward to seeing you there.

About Endexx Corporation

Endexx Corporation, through its operating division CBD Unlimited, develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of clinical research in the field and lab work to provide accuracy in dosage and delivery of optimal absorption per serving.

Endexx Corporation
Todd Davis
4805956900
endexx@endexx.com
www.endexx.com


FAQ

What is the purpose of Endexx Corporation's participation in the Benzinga Cannabis Capital Conference?

Endexx Corporation aims to increase visibility and engage with investors at the Benzinga Cannabis Capital Conference.

When will Endexx Corporation present at the Benzinga Cannabis Capital Conference?

Endexx Corporation will present on February 25-26, 2021, at 1:50 pm EST.

How can shareholders attend the Benzinga Cannabis Capital Conference?

Shareholders can register for a free spectator pass to attend the Benzinga Cannabis Capital Conference.

What products does Endexx Corporation offer?

Endexx Corporation offers all-natural CBD products, including oils, capsules, topicals, and pet products.

What is the focus of Endexx's products?

Endexx's products focus on therapeutic and pain relief, based on clinical research.

ENDEXX CORP

OTC:EDXC

EDXC Rankings

EDXC Latest News

EDXC Stock Data

5.06M
474.28M
6.34%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Cave Creek